These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 1709208)
21. Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancer. Lüftner D; Mazurek S; Henschke P; Mesterharm J; Schildhauer S; Geppert R; Wernecke KD; Possinger K Anticancer Res; 2003; 23(2A):991-7. PubMed ID: 12820337 [TBL] [Abstract][Full Text] [Related]
22. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Zhang L; Chang CJ; Bacus SS; Hung MC Cancer Res; 1995 Sep; 55(17):3890-6. PubMed ID: 7543819 [TBL] [Abstract][Full Text] [Related]
23. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
24. Calcium induces tyrosine phosphorylation of a novel p120GAP-associated protein of 65 kDa. Medema JP; de Vries-Smits AM; Bos JL Oncogene; 1995 Aug; 11(4):757-62. PubMed ID: 7544452 [TBL] [Abstract][Full Text] [Related]
25. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527. Cobb BS; Parsons JT Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368 [TBL] [Abstract][Full Text] [Related]
26. Role of intracellular Ca2+ in the epidermal growth factor induced inhibition of protein tyrosine phosphatase activity in a breast cancer cell line. Mishra S; Hamburger AW Biochem Biophys Res Commun; 1993 Mar; 191(3):1066-72. PubMed ID: 7682060 [TBL] [Abstract][Full Text] [Related]
27. Disulfide-linked and noncovalent dimers of p185HER-2 in human breast carcinoma cells. Lin YJ; Christianson TA; Clinton GM J Cell Biochem; 1992 Jul; 49(3):290-5. PubMed ID: 1379605 [TBL] [Abstract][Full Text] [Related]
28. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases. Torres M; Hall FL; O'Neill K J Immunol; 1993 Feb; 150(4):1563-77. PubMed ID: 7679431 [TBL] [Abstract][Full Text] [Related]
29. Evidence that a phosphotyrosine-containing 120,000 Da protein from Rous sarcoma virus-infected cells is phosphorylated by pp60v-src. Lau AF Oncogene Res; 1989; 4(3):185-94. PubMed ID: 2472591 [TBL] [Abstract][Full Text] [Related]
30. NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer. Christianson TA; Doherty JK; Lin YJ; Ramsey EE; Holmes R; Keenan EJ; Clinton GM Cancer Res; 1998 Nov; 58(22):5123-9. PubMed ID: 9823322 [TBL] [Abstract][Full Text] [Related]
31. Demonstration that LSTRA cells have an elevated level of proteins phosphorylated on tyrosine residues. Thom RE; Casnellie JE FEBS Lett; 1987 Sep; 222(1):104-8. PubMed ID: 2443387 [TBL] [Abstract][Full Text] [Related]
32. Antibodies for phosphotyrosine: analytical and preparative tool for tyrosyl-phosphorylated proteins. Wang JY Anal Biochem; 1988 Jul; 172(1):1-7. PubMed ID: 2461110 [No Abstract] [Full Text] [Related]
33. Generation and use of anti-phosphotyrosine antibodies for immunoblotting. Kamps MP Methods Enzymol; 1991; 201():101-10. PubMed ID: 1719339 [TBL] [Abstract][Full Text] [Related]
34. Validation of a phosphoprotein array assay for characterization of human tyrosine kinase receptor downstream signaling in breast cancer. Chergui F; Chrétien AS; Bouali S; Ramacci C; Rouyer M; Bastogne T; Genin P; Leroux A; Merlin JL Clin Chem; 2009 Jul; 55(7):1327-36. PubMed ID: 19443568 [TBL] [Abstract][Full Text] [Related]
35. In the absence of antibody IgGsorb precipitates human placenta phosphotyrosine-containing proteins. Goren HJ; Boland D Biochem Biophys Res Commun; 1989 Feb; 159(1):332-6. PubMed ID: 2466462 [TBL] [Abstract][Full Text] [Related]
36. Differential phosphoprotein mapping in cancer cells using protein microarrays produced from 2-D liquid fractionation. Pal M; Moffa A; Sreekumar A; Ethier SP; Barder TJ; Chinnaiyan A; Lubman DM Anal Chem; 2006 Feb; 78(3):702-10. PubMed ID: 16448042 [TBL] [Abstract][Full Text] [Related]
37. Two classes of phosphotyrosine-containing proteins detected by labeling with 32P and 125I in HeLa cells. Ohtsuka M; Ogawa R; Watanabe Y Biochem Biophys Res Commun; 1987 Jan; 142(2):389-94. PubMed ID: 2434092 [TBL] [Abstract][Full Text] [Related]
38. Phosphotyrosine-containing proteins in Dictyostelium discoideum. Schweiger A; Mihalache O; Muhr A; Adrian I FEBS Lett; 1990 Jul; 268(1):199-202. PubMed ID: 1696550 [TBL] [Abstract][Full Text] [Related]
39. Enzymatic and immunohistochemical evaluation of tyrosine phosphorylation in breast cancer specimens. Lower EE; Franco RS; Miller MA; Martelo OJ Breast Cancer Res Treat; 1993; 26(3):217-24. PubMed ID: 7504533 [TBL] [Abstract][Full Text] [Related]
40. Generation and use of anti-phosphotyrosine antibodies raised against bacterially expressed abl protein. Wang JY Methods Enzymol; 1991; 201():53-65. PubMed ID: 1719348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]